|
MechanismTSTD1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with CTxT Pty Ltd
0 Patents (Medical) associated with CTxT Pty Ltd
100 Deals associated with CTxT Pty Ltd
100 Translational Medicine associated with CTxT Pty Ltd